What is Meningococcal Disease?
Meningococcal disease is any infection caused by meningococcal bacteria (Neisseria meningitidis). It is uncommon but very serious.
About 10 per cent of the population carry meningococcal bacteria in their throat without becoming unwell. These people are known as ‘carriers’, and they can pass the disease on to someone else.
Meningococcal bacteria are passed from person to person by close, prolonged contact. In a small number of people, the bacteria can enter the bloodstream and cause invasive meningococcal disease.
There are different strains of meningococcal bacteria. You can be vaccinated against strains A, B, C, W and Y. Vaccination is the best way to prevent the spread of meningococcal disease.
A government funded Meningococcal ACWY vaccine is available for infants at 12 months of age and students in Year 10 of secondary school. Catch-up vaccination is available for young people under the age of 20 years.
Meningococcal ACWY vaccine and meningococcal B vaccines are also funded for people with specified medical risk conditions that make them more vulnerable to invasive meningococcal disease. Speak with your doctor or pharmacist about your particular circumstances if you think you may be eligible.
Privately funded vaccination is available for those not eligible under the program.
Pre-booking is recommended for this service. Whilst we do offer walk-in service at all BUFS Pharmacies, service is subject to availability and timing.
Frequently Asked Questions
-
Bendigo UFS Pharmacies are able to provide the Meningococcal ACWY and Meningococcal B vaccines.
Meningococcal B vaccine is free under the National Immunisation Program for:
Aboriginal and Torres Strait Islander children aged 2 months, 4 months, 6 months (certain medical conditions) and 12 months.
People of all ages with asplenia and hyposplenia, complement deficiency and those receiving treatment with eculizumab.
Meningococcal ACWY vaccine is free under the National Immunisation Program for:
children aged 12 months
adolescents aged 14-16 years through school-based vaccination programs.
People of all ages with asplenia and hyposplenia, complement deficiency and those receiving treatment with eculizumab.
-
The National Immunisation Program (NIP) was set up by the Commonwealth and State and Territory governments in 1997. The program aims to increase national immunisation coverage to reduce the number of cases of diseases that are preventable by vaccination in Australia. Bendigo UFS Pharmacies vaccinations are all eligible for the program and patients are only required to pay a service fee.
-
We recommend visiting www.betterhealth.com.au as a great information source. To locate Meningococcal directly visit here.
Last updated May 2025